en · de · es · fr · pt
cjc-1295-notes.peptides7501.com › Topic › Receptor Action And Pharmacokinetics — Research Overview

Receptor Action And Pharmacokinetics — Research Overview

By Editorial Desk · published 2026-07-29 · last reviewed 2026-08-01 · Topic

GHRH receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.

Receptor Action and Pharmacokinetics

CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.

The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.

Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.

Mechanism and Pharmacokinetics

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Cjc-1295 at a glance

PropertyValueNotes
Primary targetGHRH receptorG-protein-coupled receptor on pituitary somatotrophs
Half-life, long-acting formSeveral daysExtended by covalent albumin binding
Half-life, short formAbout 30 minutesCleared rapidly by peptidases and kidneys
Route in studiesSubcutaneous injectionUsed in the published human trials
Main measured effectRise in GH and IGF-1Surrogate markers rather than clinical endpoints

CJC-1295 Structure And Mechanism

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Related pages on this site

Structure And Receptor Pharmacology

CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Reference notes

Posaconazole, sold under the brand name Noxafil among others, is a triazole antifungal medication. It was approved for medical use in the European Union in October 2005, and in the United States in September 2006. It is available as a generic medication.

=== Hypersaline environment === As sea ice forms, the water freezes into a lattice structure; this process ejects many of the salts and microbes from the ice, concentrating them in the remaining water. This high-salinity seawater is known as brine, and as more salts accumulate within the brine pockets, the remaining brine becomes more resistant to freezing. This accumulation of salts, producing a liquid environment that can remain liquid in subzero temperatures, provides a harsh-but-suitable environment for microorganisms to survive. These brine pockets maintain a very saline environment, have high concentrations of other dissolved minerals, and have a high density of microbial life. Brine salinity and concentration are directly dependent on the air temperature of the surrounding environment; as temperatures decrease, more salts become rejected from newly-formed ice, causing more salts to accumulate within the brine, and brine pockets decrease in size. This results in a hypersaline environment with dissolved salt contents which can reach up to 200 g/kg, in contrast to open seawater which has a salinity of 33-37 g/kg.

The brand became a well-established franchise in the Philippines, where it began in 1975 under the ownership of the country's largest food conglomerate, San Miguel Corporation, primarily promoting their San Miguel draft beer. Beginning with a restaurant located on Makati Avenue in Makati, the restaurant expanded rapidly in Metro Manila, with most of its outlets offering live music. San Miguel had difficulty maintaining the consistency of the branches, and ultimately sold the franchise in 1987 to International Family Food Services, Inc. (IFFSI), a group led by the family of sports executive Leo Prieto. In 1997, it had evolved into mostly a fast-food franchise. The brand was reengineered as a family-oriented casual dining brand in 2003. In 2004, Shakey's partnered with Sports Vision for the launch of the Shakey's V-League, one of the pioneering volleyball leagues in the country. The Shakey's Super League was formally launched on August 16, 2022, at the Shakey's Pizza Aseana City outlet in Parañaque. This marks the return of Shakey's Pizza in Philippine volleyball since they served as the title sponsor for the Shakey's V-League (now Premier Volleyball League) from 2004 to 2017. As of early 2015, there were 153 Shakey's outlets in the Philippines, more than double the number remaining in the United States. In March 2016, the Century Pacific Group and the Singapore-based GIC Private Limited acquired the majority shares of IFFSI from the Prieto family, which will retain a minority interest in the company.

Sources: en.wikipedia.org

Notes from published material

To grant a pardon or amnesty. To appoint the Commander-in-Chief of Defence Services Declare a state of emergency with the approval from the National Defence and Security Council Appoint and remove Cabinet ministers

Ganglioside-induced differentiation-associated protein 1 is a type of protein that in humans is encoded by the GDAP1 gene. This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot–Marie–Tooth disease and neuropathy. Two transcript variants encoding different isoforms have been identified for this gene.

Coca leaves have been used by indigenous South Americans for thousands of years, both as a stimulant and for medicinal purposes. When the Spanish arrived in South America, they initially banned coca but soon legalized and taxed it after seeing its importance to local labor. The active ingredient was first isolated in 1855 by Friedrich Gaedcke and later refined by Albert Niemann, who named it "cocaine". In the late 1800s, cocaine became popular in Western medicine as a local anesthetic and was widely used in various products, including drinks and remedies. and James Leonard Corning demonstrated peridural anesthesia. However, due to its toxic effects and potential for abuse, safer alternatives eventually replaced it in medical practice. Large-scale coca cultivation and cocaine production occurred in Asia, on Taiwan (then known as Formosa) and Java (today part of Indonesia) before World War II. Since the 1980s, the cocaine trade was dominated by centralized, hierarchical drug cartels such as Medellín and Cali, along with their successors and early FARC factions. By the early 2000s, this model fragmented into a diverse network of global trafficking links, allowing South American cocaine production to easily supply markets in Europe, Africa, Asia, and Oceania through various routes.

Sources: en.wikipedia.org

Background from the literature

In June 1945, the squadron initially flew missions with the 310th Fighter Squadron, often twice a day, using borrowed U.S. aircraft. It received 25 new P-47D-30-RA aircraft in July, marked with the insignia of both the USAAF and Mexican Air Force. The squadron flew more than 90 combat missions, totaling more than 1,900 hours of flight time. It participated in the Allied effort to bomb Luzon and Formosa to push the Japanese out of those islands. It relentlessly attacked the Japanese forces concentrated mainly in Luzon and flew 53 combat missions as part of the U.S. Air Force warfare organization, was specified in the support of the 25th Infantry Division, the Philippine Army, as well as numerous Filipino guerrillas, to open up into the Cagayan valley where the squadron devastated the Japanese defenses on the ground with its bombs. Close support missions consisted mainly of attacking resistance points, apart from these they launched attacks on bases, fortifications, supply routes and machine gun pits. During its fighting in the Philippines, five squadron pilots died (one was shot down, one crashed, and three ran out of fuel and died at sea); and three others died in accidents during training. The pilot Héctor Espinoza Galván was flying together with an American pilot but he ran out of fuel and fell into the ocean; His body was never found. Captain Pablo Ribaz Martínez and Second Lieutenant Guillermo García Ramos were surrounded by a storm, Ribaz Martínez dying while García Ramos survived after being rescued.

== Catabolism and clearance == The half-life of Lp(a) in circulation is approximately three to four days. The mechanism and sites of Lp(a) catabolism are largely unknown. The LDL receptor has been reported as a receptor for Lp(a) clearance, but is not a major pathway of Lp(a) metabolism under normal or hypercholesterolemic conditions. The kidney has been identified as playing a role in Lp(a) clearance from plasma.

=== Peak width definition === In the peak width definition, the value of ΔM is the width of the peak measured at a specified fraction of the peak height, for example 0.5%, 5%, 10% or 50%. The latter is called the full width at half maximum (FWHM).

Sources: en.wikipedia.org

Frequently asked questions

How does CJC-1295 raise growth hormone levels?

It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.

Why does the DAC form last longer?

The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.

What remains uncertain about its effects?

Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.

How long does the albumin-binding form remain active?

Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.

Network